Keck School of Medicine

The Hologic-funded model predicted co-testing would lead to a lifetime savings of $39 per woman, with high cancer detection sensitivity and fewer false positive results.

NEW YORK (GenomeWeb) — A public-private team led by researchers at the Keck Graduate Institute of Life Sciences has been awarded just over $600,000 by the National Institutes of Health for the first year of a four-year project to further develop its point-of-care nucleic acid testing platform for

NEW YORK (GenomeWeb) – Cancer Genetics today said that it will collaborate with a researcher at Keck Medicine of the University of Southern California to identify genomic markers of diffuse large B-cell lymphoma.

WaferGen Biosystems and collaborators in the laboratory of Jo Vandesompele at the University of Ghent have developed a PCR-based target enrichment workflow using WaferGen's SmartChip real-time PCR system, the company said this week.

The grant will help USC spinout Pivotal Biosciences, which was co-founded by researcher Alan Epstein, push the immunotherapy through to clinical trials — a task that would otherwise be near impossible for the company due to a dearth of private funding caused by the recent financial meltdown.

For labs looking to complement — and, in some cases, replace — gene expression microarrays with RNA-seq, data analysis remains a major hurdle.

American and British researchers assessed DNA methylation patterns in colorectal cancers from a dozen patients to try to understand clonal expansion and cancer stem cell patterns in these tumors.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.